StockData
Pulse Biosciences, Inc. logo

Pulse Biosciences, Inc. (PLSE) stock

PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$45.83+0.99 (+2.21%)

Close on Nov 18, 2026Market cap $3.27BP/E –Yield –

Pulse Biosciences revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Pulse Biosciences's revenue for the twelve months ending Jun 30, 2026 was $1.19M. For fiscal 2025 it was $350.00K. The highest annual figure on record is $1.42M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$350.00K–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$700.00K-50.6%
FY2021Dec 31, 2021$1.42M–
FY2020Dec 31, 2020$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$434.00K–
Q1 FY2026Mar 31, 2026$401.00K–
Q4 FY2025Dec 31, 2025$264.00K–
Q3 FY2025Sep 30, 2025$86.00K–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0–
Q1 FY2024Mar 31, 2024$0–
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q3 FY2022Sep 30, 2022$0-100.0%
Q2 FY2022Jun 30, 2022$265.00K–
Q1 FY2022Mar 31, 2022$444.00K–
Q4 FY2021Dec 31, 2021$844.00K–
Q3 FY2021Sep 30, 2021$574.00K–

More Pulse Biosciences figures

See a number that looks wrong?